: Russia’s Sputnik V COVID-19 vaccine shows 91.6% efficacy in late-stage trial 1 de fevereiro de 2021 by r4ibom in Uncategorized Preliminary findings, published in The Lancet on Tuesday, are based on data gathered from 19,866 participants. Compartilhe isso: Clique para compartilhar no X(abre em nova janela) 18+ Clique para compartilhar no Facebook(abre em nova janela) Facebook 1 de fevereiro de 2021
